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Abstract: Complex atheromatosis of the aortic arch has been increasignly recognized as a cause of cerebral infarction 
in patients with stroke of uncertain etiology. The incorporation of transesophageal echocardiographic studies in routine 
clinical practice allows direct visualization of cardiac and vascular structures previously innaccessible, including 
atherosclerotic plaques in the aortic arch. Large atheromatous plaques, which protrude strikingly into the aortic arch 
lumen and have obvious mobile components are associated with a high probability of being the etiology of embolism. 
Aortic arch atheromatosis should be considered a dynamic process entailing a non-negligible risk of recurrent 
cardiovascular events. Therefore, adequate diagnosis and optimal treatment is mandatory for secondary prevention of 
cerebral ischemic infarction and progression of aortic arch atheromas. 
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INTRODUCTION 
Approximately between 15% and 42% of all cases 
of cerebral infarction collected in the main hospital-
based stroke registries are cases of ischemic stroke of 
unknown origin [1-3]. The most frequent etiological 
subtypes of focal cerebral ischemia are cardioembolic 
infarctions, atherothrombotic infarctions, and lacunar 
infarctions, which account for 55-75% of all cerebral 
ischemic infarcts [1-3, 4]. Cerebral infarcts of unusual 
cause account only for 5-10% of all infarcts and are 
usually associated with hematological diseases, arterial 
dissection, inflammatory or infectious arteritis as well 
as a large list of miscellaneous entities, with stroke as 
the presenting manifestation or complicating the natural 
course of the disease [5]. Finally, there is a group of 
stroke patients in whom the etiology of cerebral 
ischemia is unknown because appropriate diagnostic 
procedures are not performed, presence of two 
possible pathological conditions responsible for stroke 
concomitantly, or despite performance of a battery of 
adequate diagnostic work-up studies, the cause of 
stroke remains unclear. Patients included in the last 
group are those with true cerebral infarction of 
undetermined cause in which the use of more 
extensive complementary diagnostic studies may be 
required (such as transesophageal echocardiography, 
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angiography, screening of hematological disorders with 
prothrombotic risk, testing for factor V Leiden, protein C 
or S deficiency, antithrombin III deficiency, etc.) [6]. 
In this subgroup of patients with cerebral ischemic 
stroke of essential etiology, complex atheromatosis of 
the aortic arch is currently an emerging diagnosis. 
CEREBRAL ISCHEMIA AND COMPLEX ATHERO- 
MATOSIS OF THE AORTIC ARCH 
It has been reported that aortic plaques of  4 mm 
thick are the second most prevalent embolic risk factor 
for stroke after atrial fibrillation, and are present in 16% 
to 20% of all stroke and transient ischemic attack (TIA) 
patients. Also, the presence of aortic atheromatous 
plaques is a risk for new and recurrent stroke [7]. 
In patients with ischemic cerebral infarction in which 
routine diagnostic examinations are negative to identify 
the cause of stroke, it is useful to perform a 
transesophageal echocardiographic study, with the 
objective to exclude the presence of complex 
atheromatous plaques in the aortic arch, particularly in 
patients with concurrent risk factors for atheromatosis 
(advanced age, smoking, hypertension, diabetes) [6]. 
The use of transesophageal echocardiography has 
contributed to optimize the diagnosis of complex aortic 
arch atheromatosis. At present, the association 
between ischemic stroke and complex aortic arch 
atheromatosis is well established, mainly in the 
following circumstances: 1) when the atheroma is 
located proximal to the ostium of the left subclavian 
2    International Journal of Cardiology and Lipidology Research, 2015, Vol. 2, No. 1 Arboix and García-Batanero 
artery, 2) when the plaque is > 4 mm thick or with 
mobile component (aortic debris), and 3) when there is 
evidence of ulceration and hypogenicity (which 
probably indicate a high lipid content in the plaque) [8]. 
An analysis of different reviews shows that the 
presence of complex atheromatosis of the aortic arch is 
an independent predictor of any new arterial cerebral 
and peripheral vascular events [8]. 
Complex aortic arch atheromatosis is a proven 
cause of cerebral ischemia. In the recent clinical study 
of Wang et al. [9] of 116 patients with cerebral 
infarction, 70 had aortic atherosclerotic plaques (5.7% 
in the ascending aorta, 77.1% at the arch, 17.1% in the 
descending aorta), and 64/70 had carotid 
atherosclerotic plaques too (46 were unstable). 
Moderate/severe aortic atherosclerotic plaques and 
unstable carotid plaques are significant causes of 
embolic cerebral infarction without stenosis of the 
internal carotid arteries [9]. In the study of Sharifkazemi 
et al. [10], aortic atheroma was present in 25% of 
elderly ischemic stroke patients (underwent 
transesophageal echocardiography) without significant 
carotid artery stenosis. 
Complex atheromatosis of the aortic arch was also 
frequent in patients with TIA: about 14% of TIA patients 
had severe aortic arch atheromatosis with at least one 
plaque over than 4 mm [11] similarly to what is 
observed in patients with cerebral infarction. 
In a clinical study carried out in 248 patients who 
were discharged from the hospital with the diagnosis of 
cerebral infarction of unknown cause and receiving 
conventional platelet anti-aggregant therapy, after 1 
year of follow-up, 17 patients (6.9%) presented a 
recurrent cerebral infarct. The transesophageal 
echocardiography established the diagnosis of complex 
atheromatosis of the aortic arch in 14 cases (82.4%) 
[12]. 
In a study of 71 patients with a first ever lacunar 
infarct (9 of uncertain etiology) it was observed that 7 
patients presented simple aortic plaques and 13 
complex aortic atheroma plaques (18.3%). Of the 71 
patients, 9 presented lacunar infarctions of unknown 
cause (12.6%), that is, none of them had hypertension, 
diabetes, or any other vascular risk factor, and did not 
meet criteria of cardioembolism, atherothrombosis or 
ischemia of unusual cause. The frequency of complex 
atheromatosis of the aortic arch was more frequent in 
lacunar stroke of unknown etiology (3 of 9 cases; 33%) 
than in the remaining lacunar stroke patients (10 of 62 
cases; 16.3%). These results indicate that complex 
aortic arch atheromatosis should be ruled out in 
essential lacunar infarct patients [13]. 
In patients with ischemic stroke of uncertain etiology 
dense mitral annular calcification is an important 
marker of complex aortic atheroma. In the study of 
Pujadas et al. [14], dense mitral annular calcification  
5 mm was found in 58.3% of patients with complex 
atheromatosis of the aortic arch as compared with 
16.3% in those without complex aortic arch 
atheromatosis (P < 0.001). Plaques with mobile 
component (grade III) were documented in 28% of 
patients with dense mitral annular calcification and in 
9.9% of patients without dense mitral annular 
calcification (P < 0.01) [14]. The association of dense 
mitral annular calcification and complex aortic 
atheroma may explain in part the high prevalence of 
ischemic stroke and peripheral embolism in patients 
with mitral annular calcification. 
In the study of Okuzumi et al. [15], mobile and 
ulcerative aortic plaques were observed in 18% of 
patients with unexplained ischemic stroke. In this study, 
advanced age and the low-density lipoprotein (LDL)-
cholesterol/high-density lipoprotein (HDL)-cholesterol 
ratio of 2.23 were substantially higher and closely 
associated with mobile and ulcerative aortic plaques. A 
study of 63 patients with cryptogenic stroke using 
diffusion-weighted MR imaging (DWI) and multidetector 
row CT revealed the presence of vulnerable aortic arch 
atheromatosis in 23.8% of the cases [16]. These 
patients had more risk of having a DWI pattern 
characterized by multiple, small, scattered lesions in 
multiple vascular territories [16]. 
All these studies show that complex atheromatosis 
of the aortic arch is associated with ischemic stroke of 
unknown cause, stroke recurrence and all vascular 
events [17, 18]. 
Magnetic resonance imaging (MRI) can be useful to 
assess the characteristics of the aortic atheroma 
plaque and its components (presence of calcification, 
lipid composition, presence of thrombi). However, MRI 
is contraindicated in patients with prosthetic valves, 
carriers of pacemakers and defibrillators as well as in 
claustrophobic patients and is less effective in the 
detection of mobile thrombi as compared to 
transesophageal echocardiography (TEE) [17]. High-
resolution helicoïdal computed tomography would be of 
particular interest in the study of areas not visualized 
by TEE (the distal ascending aorta) [17]. 
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TREATMENT 
In the ARCH clinical trial (Aortic Arch Related 
Cerebral Hazard) patients with ischemic stroke and 
aortic arch plaques > 4 mm treated with aspirin (75 to 
150 mg/day) plus clopidogrel (75 mg/day) had a non-
significant 24% reduction in the rate of recurrent stroke 
(including intracerebral hemorrhage), myocardial 
infarction, peripheral embolism, and vascular death 
compared with patients on warfarin therapy (INR 2-3) 
[19] After a median follow-up of 3.4 years, the primary 
end point (which included cerebral infarction, 
myocardial infarction, peripheral embolism, vascular 
death, or intracranial hemorrhage) occurred in 7.6% on 
patients treated with aspirin plus clopidogrel and in 
13.6% on warfarin therapy (P = 0.2). It was observed 
more intracranial hemorrhages in the long treatment 
aspirin plus clopidogrel therapy, and the authors 
suggested a short-term term use (3 months) of the 
combination, followed by long-term clopidogrel 
monotherapy. The authors also recommended that 
future trials are required to clarify the optimal therapy 
for ischemic stroke attributed to aortic arch 
atheromatosis (for example to compare an antiplatelet 
strategy with one of the new anticoagulants) [19]. 
Patients with atherosclerosis in the aortic arch 
should also be treated with statins (to achieve a LDL-
cholesterol level of 70 to 80 mg/dL). Statins reduce 
vascular wall thickness, increasing the luminal area, 
and are used as secondary stroke prevention even in 
the presence of normal levels of cholesterol. Also, 
treatment of associated cardiovascular risk factors is 
mandatory (e.g. blood pressure-lowering agents to 
reduce high blood pressure < 130/85 mm Hg). 
However, in patients with complex aortic 
atheromatosis plaques with mobile components, which 
constitute the subgroup of patients at the highest risk of 
embolism, therapeutic options are not well defined, and 
in the absence of randomized trials comparing the 
efficacy of different antithrombotic strategies in this 
specific patient population, it seems that therapeutic 
anticoagulation is the first-line treatment according to 
experts recommendations. 
Data supporting the indication of surgical treatment 
for complex atheromatosis of the aortic arch are 
currently lacking. Aortic arch endarterectomy should be 
restricted to cases of embolic recurrences resistant to 
anticoagulation treatment at therapeutic doses [17]. 
PROGNOSIS 
Complex atheromatosis of the aortic arch should be 
viewed as a marker of a very severe atherosclerotic 
disease involving not only the aorta but also coronary, 
peripheral and carotid/vertebral arteries [8]. In a recent 
study carried out in 149 hospitalized patients with first-
ever cerebral infarction of unknown origin, thick aortic 
arch plaques was a factor in the prediction of poor 
prognosis [20]. 
 
Figure 1: Transesophageal echocardiogram showing an aortic arch complex atheromatosis plaque with a mobile component. In 
these circumstances the risk of embolism is very high. 
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Aortic arch atheromatosis is a dynamic process with 
progression noted in 29% of patients [18]. Progression 
of complex atheromatosis of the aortic arch is 
associated with the presence of recurrent vascular 
events. A study of TEE in 117 patients with stroke/TIA 
with aortic arch atheroma at 12 months follow-up of the 
vascular event, showed the aortic arch atheroma 
progression in 28% of them (n= 33). This subgroup of 
patients presented a higher prevalence of complex 
mobile plaque and vascular events (myocardial infarct, 
TIA, stroke, vascular death) than the subgroup without 
progression (55% vs. 8%).  
It is important to establish an adequate diagnosis of 
complex atheromatosis of the aortic arch to indicate the 
optimal treatment for both secondary prevention of 
cerebral ischemia and progression of the aortic 
atheromatosis. 
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